Agenus Inc Sustainability Reports
Agenus Inc. is a clinical-stage immuno-oncology company focused on the discovery and development of therapies that engage the body's immune system to fight cancer.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900NDQQGU5H4UJK81
FIGI: BBG001SDV370
9 reports from 2013 to 2024
